MA27113A1 - Activateurs de glucokinase oxygenes cycloalkyle ou substitues cycloalkyle - Google Patents
Activateurs de glucokinase oxygenes cycloalkyle ou substitues cycloalkyleInfo
- Publication number
- MA27113A1 MA27113A1 MA27915A MA27915A MA27113A1 MA 27113 A1 MA27113 A1 MA 27113A1 MA 27915 A MA27915 A MA 27915A MA 27915 A MA27915 A MA 27915A MA 27113 A1 MA27113 A1 MA 27113A1
- Authority
- MA
- Morocco
- Prior art keywords
- cycloalkyl
- glucokinase
- substituted
- oxygen activators
- substituted cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
- C07C275/48—Y being a hydrogen or a carbon atom
- C07C275/50—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
PHENYLACETAMIDES SUBSTITUES ET LEUR UTILISATION EN TANT QU'ACTIVATEURS DE LA GLUCOKINASE Les composés de formule I; dans laquelle la formule II représente un groupe substitué, un groupe oxa-cycloalkyle ou un groupe thia-cycloalkyle, sont des activateurs de la glucokinase utiles dans le traitement du diabète de type II.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37616102P | 2002-04-26 | 2002-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27113A1 true MA27113A1 (fr) | 2004-12-20 |
Family
ID=29420328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA27915A MA27113A1 (fr) | 2002-04-26 | 2004-10-26 | Activateurs de glucokinase oxygenes cycloalkyle ou substitues cycloalkyle |
Country Status (35)
Country | Link |
---|---|
US (2) | US7105671B2 (fr) |
EP (1) | EP1501815B1 (fr) |
JP (1) | JP4091600B2 (fr) |
KR (1) | KR100669587B1 (fr) |
CN (1) | CN1329386C (fr) |
AR (1) | AR039665A1 (fr) |
AT (1) | ATE346056T1 (fr) |
AU (1) | AU2003232204B8 (fr) |
BR (1) | BR0309546A (fr) |
CA (1) | CA2482346C (fr) |
DE (1) | DE60309856T2 (fr) |
DK (1) | DK1501815T3 (fr) |
EA (1) | EA011297B1 (fr) |
EC (1) | ECSP045382A (fr) |
ES (1) | ES2276097T3 (fr) |
GT (1) | GT200300096A (fr) |
HK (1) | HK1078088A1 (fr) |
HR (1) | HRP20040953A2 (fr) |
IL (1) | IL164780A (fr) |
MA (1) | MA27113A1 (fr) |
MX (1) | MXPA04010605A (fr) |
MY (1) | MY135222A (fr) |
NO (1) | NO20044534L (fr) |
NZ (1) | NZ535706A (fr) |
PA (1) | PA8572301A1 (fr) |
PE (1) | PE20040451A1 (fr) |
PL (1) | PL373701A1 (fr) |
PT (1) | PT1501815E (fr) |
RS (1) | RS93604A (fr) |
TN (1) | TNSN04211A1 (fr) |
TW (1) | TWI281917B (fr) |
UA (1) | UA80427C2 (fr) |
UY (1) | UY27787A1 (fr) |
WO (1) | WO2003095438A1 (fr) |
ZA (1) | ZA200407986B (fr) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04115996U (ja) * | 1991-03-28 | 1992-10-15 | 東洋運搬機株式会社 | ボートリフタ |
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
BR0314864A (pt) * | 2002-10-03 | 2005-08-02 | Novartis Ag | Compostos orgânicos |
GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
PL378117A1 (pl) * | 2003-02-11 | 2006-03-06 | Prosidion Limited | Tricyklopodstawione związki amidowe |
CA2554310A1 (fr) | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Derives de benzamide et leur utilisation en tant qu'activateurs de la glucokinase |
RU2412192C2 (ru) | 2004-04-02 | 2011-02-20 | Новартис Аг | Сульфонамидтиазолпиридиновые производные как активаторы глюкокиназы, пригодные для лечения диабета типа 2 |
RU2006138426A (ru) | 2004-04-02 | 2008-05-10 | Новартис АГ (CH) | Производные тиазолопиридина, содержащие их фармацевтические композиции и способы лечения состояний, опосредованных глюкокиназой |
EP1740560A1 (fr) * | 2004-04-21 | 2007-01-10 | Prosidion Limited | Composes amide tri(cyclo)-substitues |
TW200600086A (en) | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
GB0418046D0 (en) * | 2004-08-12 | 2004-09-15 | Prosidion Ltd | Eantioselective process |
CA2576407A1 (fr) * | 2004-08-12 | 2006-02-16 | Prosidion Limited | Phenylacetamides substitues et leur utilisation en tant qu'activateurs de la glucokinase |
GB0418058D0 (en) * | 2004-08-12 | 2004-09-15 | Prosidion Ltd | Fluorination process |
NZ575512A (en) | 2005-07-09 | 2009-11-27 | Astrazeneca Ab | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
RU2420525C2 (ru) | 2005-07-11 | 2011-06-10 | Мицубиси Танабе Фарма Корпорейшн | Производные оксимов и их получение |
RU2008112184A (ru) | 2005-08-31 | 2009-10-10 | Астеллас Фарма Инк. (Jp) | Производное тиазола |
JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
NZ566877A (en) | 2005-09-29 | 2010-05-28 | Sanofi Aventis | Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
GT200600429A (es) | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
GT200600428A (es) | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
JP2009512724A (ja) | 2005-10-24 | 2009-03-26 | エフ.ホフマン−ラ ロシュ アーゲー | Favorskii転位による環状ケタール化ケトンの製造およびグルコキナーゼ活性化剤:70を製造するためのその使用 |
US20080293741A1 (en) * | 2005-11-03 | 2008-11-27 | Matthew Colin Thor Fyfe | Tricyclo Substituted Amides as Glucokinase Modulators |
WO2007104034A2 (fr) | 2006-03-08 | 2007-09-13 | Takeda San Diego, Inc. | Activateurs de la glucokinase |
WO2007115968A2 (fr) * | 2006-04-12 | 2007-10-18 | F. Hoffmann-La Roche Ag | Procédé de préparation d'un activateur de glucokinase |
WO2007115967A1 (fr) * | 2006-04-12 | 2007-10-18 | F. Hoffmann-La Roche Ag | Solvate d'isopropanol cristallin de l'activateur de la glucokinase |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
JP5386350B2 (ja) | 2006-05-31 | 2014-01-15 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体 |
PT2248812E (pt) * | 2006-06-27 | 2014-03-12 | Takeda Pharmaceutical | Compostos cíclicos fundidos como moduladores do receptor gpr40 |
US7910747B2 (en) | 2006-07-06 | 2011-03-22 | Bristol-Myers Squibb Company | Phosphonate and phosphinate pyrazolylamide glucokinase activators |
US7888504B2 (en) | 2006-07-06 | 2011-02-15 | Bristol-Myers Squibb Company | Glucokinase activators and methods of using same |
WO2008012227A2 (fr) | 2006-07-24 | 2008-01-31 | F. Hoffmann-La Roche Ag | Pyrazoles comme activateurs de glucokinase |
TW200819457A (en) | 2006-08-30 | 2008-05-01 | Actelion Pharmaceuticals Ltd | Spiro antibiotic derivatives |
CL2007003061A1 (es) | 2006-10-26 | 2008-08-01 | Astrazeneca Ab | Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2. |
US7902248B2 (en) * | 2006-12-14 | 2011-03-08 | Hoffmann-La Roche Inc. | Oxime glucokinase activators |
WO2008074694A1 (fr) * | 2006-12-20 | 2008-06-26 | F. Hoffmann-La Roche Ag | Cristallisation d'activateurs de glucokinase |
US8163779B2 (en) | 2006-12-20 | 2012-04-24 | Takeda San Diego, Inc. | Glucokinase activators |
TW200831081A (en) * | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
WO2008080824A1 (fr) * | 2006-12-29 | 2008-07-10 | F. Hoffmann-La Roche Ag | Cétales aromatiques sulfonés |
WO2008080822A1 (fr) * | 2006-12-29 | 2008-07-10 | F. Hoffmann-La Roche Ag | Méthodologies d'épimérisation permettant le recueil de stéréoisomères très purs avec un bon rendement |
EP2105435A4 (fr) | 2007-01-10 | 2011-06-15 | Mitsubishi Tanabe Pharma Corp | Dérivé d'hydrazone |
CN101687800B (zh) * | 2007-03-07 | 2012-03-21 | 杏林制药株式会社 | 葡糖激酶活化物质 |
WO2008116107A2 (fr) | 2007-03-21 | 2008-09-25 | Takeda San Diego, Inc. | Activateurs de glucokinase |
AU2008310519B2 (en) * | 2007-10-08 | 2013-05-02 | Advinus Therapeutics Private Limited | Acetamide derivatives as glucokinase activators, their process and medicinal applications |
BRPI0906888A2 (pt) | 2008-01-18 | 2015-11-03 | Astellas Pharma Inc | derivado de fenilacetamida |
US7741327B2 (en) | 2008-04-16 | 2010-06-22 | Hoffmann-La Roche Inc. | Pyrrolidinone glucokinase activators |
US8258134B2 (en) | 2008-04-16 | 2012-09-04 | Hoffmann-La Roche Inc. | Pyridazinone glucokinase activators |
EP2275414B1 (fr) * | 2008-04-28 | 2015-06-10 | Kyorin Pharmaceutical Co., Ltd. | Dérivé d'amide cyclopentylacrylique |
US20110021570A1 (en) | 2009-07-23 | 2011-01-27 | Nancy-Ellen Haynes | Pyridone glucokinase activators |
US8222416B2 (en) | 2009-12-14 | 2012-07-17 | Hoffmann-La Roche Inc. | Azaindole glucokinase activators |
ES2893699T3 (es) | 2010-03-31 | 2022-02-09 | Scripps Research Inst | Reprogramación de células |
US8178689B2 (en) | 2010-06-17 | 2012-05-15 | Hoffman-La Roche Inc. | Tricyclic compounds |
EP2878339A1 (fr) | 2013-12-02 | 2015-06-03 | Siena Biotech S.p.A. | Antagonistes SIP3 |
TWI756257B (zh) | 2016-08-31 | 2022-03-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 吡啶酮醯胺類衍生物、其製備方法及其在醫藥上的應用 |
GB201714777D0 (en) | 2017-09-14 | 2017-11-01 | Univ London Queen Mary | Agent |
US11076596B2 (en) | 2017-09-18 | 2021-08-03 | Basf Se | Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE249241C (fr) | 1910-05-01 | 1912-07-13 | ||
US3431301A (en) | 1966-03-24 | 1969-03-04 | Hoffmann La Roche | Process for producing methylhydrazine derivatives |
US3776917A (en) | 1972-06-05 | 1973-12-04 | Schering Corp | 2-amino-6-phenalkyl-aminopyridines and derivatives thereof |
ES419319A1 (es) | 1973-10-04 | 1976-03-01 | Gallardo Antonio Sa | Un procedimiento para la obtencion de derivados de acidos 3-benzoilfenilalcanoicos. |
GB8909574D0 (en) | 1989-04-26 | 1989-06-14 | Ici Plc | Chemical process |
US5169951A (en) | 1990-04-23 | 1992-12-08 | Ciba-Geigy Corporation | Process for preparing nematicidal compositions |
EP0566138B1 (fr) | 1992-04-17 | 1998-11-18 | Hodogaya Chemical Co., Ltd. | Amino thiazoles et leur utilisation comme fongicides |
US5556859A (en) | 1994-12-22 | 1996-09-17 | Dowelanco | N-(4-pyrimidinyl)amide pesticides |
GB9823871D0 (en) | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
NZ514038A (en) * | 1999-03-29 | 2004-01-30 | Hoffmann La Roche | Glucokinase activators |
PT1305301E (pt) * | 2000-07-20 | 2005-09-30 | Hoffmann La Roche | Benzeno-acetamidas alfa-acilo e alfa-heteroatomo-substituidas activadoras da glucocinase |
-
2003
- 2003-04-14 RS YUP-936/04A patent/RS93604A/sr unknown
- 2003-04-14 EP EP03749855A patent/EP1501815B1/fr not_active Expired - Lifetime
- 2003-04-14 ES ES03749855T patent/ES2276097T3/es not_active Expired - Lifetime
- 2003-04-14 WO PCT/EP2003/003844 patent/WO2003095438A1/fr active IP Right Grant
- 2003-04-14 DE DE60309856T patent/DE60309856T2/de not_active Expired - Lifetime
- 2003-04-14 MX MXPA04010605A patent/MXPA04010605A/es active IP Right Grant
- 2003-04-14 CN CNB038093839A patent/CN1329386C/zh not_active Expired - Fee Related
- 2003-04-14 JP JP2004503454A patent/JP4091600B2/ja not_active Expired - Fee Related
- 2003-04-14 EA EA200401398A patent/EA011297B1/ru not_active IP Right Cessation
- 2003-04-14 BR BR0309546-0A patent/BR0309546A/pt not_active IP Right Cessation
- 2003-04-14 KR KR1020047017204A patent/KR100669587B1/ko not_active IP Right Cessation
- 2003-04-14 AU AU2003232204A patent/AU2003232204B8/en not_active Ceased
- 2003-04-14 NZ NZ535706A patent/NZ535706A/en unknown
- 2003-04-14 PT PT03749855T patent/PT1501815E/pt unknown
- 2003-04-14 UA UA20041109723A patent/UA80427C2/uk unknown
- 2003-04-14 PL PL03373701A patent/PL373701A1/xx not_active Application Discontinuation
- 2003-04-14 AT AT03749855T patent/ATE346056T1/de active
- 2003-04-14 DK DK03749855T patent/DK1501815T3/da active
- 2003-04-14 CA CA002482346A patent/CA2482346C/fr not_active Expired - Fee Related
- 2003-04-23 TW TWSUBSTITUTA patent/TWI281917B/zh active
- 2003-04-23 US US10/421,109 patent/US7105671B2/en not_active Expired - Fee Related
- 2003-04-24 MY MYPI20031564A patent/MY135222A/en unknown
- 2003-04-24 GT GT200300096A patent/GT200300096A/es unknown
- 2003-04-24 PE PE2003000409A patent/PE20040451A1/es not_active Application Discontinuation
- 2003-04-24 AR ARP030101426A patent/AR039665A1/es active IP Right Grant
- 2003-04-24 PA PA20038572301A patent/PA8572301A1/es unknown
- 2003-04-28 UY UY27787A patent/UY27787A1/es not_active Application Discontinuation
-
2004
- 2004-10-04 ZA ZA200407986A patent/ZA200407986B/xx unknown
- 2004-10-12 HR HR20040953A patent/HRP20040953A2/hr not_active Application Discontinuation
- 2004-10-20 TN TNP2004000211A patent/TNSN04211A1/fr unknown
- 2004-10-21 IL IL164780A patent/IL164780A/en not_active IP Right Cessation
- 2004-10-21 NO NO20044534A patent/NO20044534L/no not_active Application Discontinuation
- 2004-10-22 EC EC2004005382A patent/ECSP045382A/es unknown
- 2004-10-26 MA MA27915A patent/MA27113A1/fr unknown
-
2006
- 2006-01-17 HK HK06100724A patent/HK1078088A1/xx not_active IP Right Cessation
- 2006-04-10 US US11/402,167 patent/US7259166B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27113A1 (fr) | Activateurs de glucokinase oxygenes cycloalkyle ou substitues cycloalkyle | |
DE60332137D1 (en) | Cyclohexyl-sulphone als gamma-sekretase-inhibitoren | |
ATE401076T1 (de) | Chinolinderivate als glucokinase liganden | |
TNSN02022A1 (fr) | Triazolopyridines anti-inflammatoires nouvelles, et compositions les contenant | |
DE60112957D1 (de) | Sulfamide als gamma-secretase-inhibitoren | |
SE0001899D0 (sv) | New compounds | |
GB0225474D0 (en) | Therapeutic agents | |
EA200300717A1 (ru) | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов | |
ATE487493T1 (de) | Azolsäure-derivate, allein oder kombiniert, zur behandlung von diabetes und dyslipidaemien; und zur behandlung von malignen erkrankungen | |
MA27643A1 (fr) | Utilisation de n-alkyl-4-methyleneamino-3-hydroxy-2-pyridones en tant qu'agents antimicrobiens | |
GB0225475D0 (en) | Therapeutic agents | |
BRPI0413449A (pt) | compostos de quinoxalina | |
MA26877A1 (fr) | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant | |
ATE510562T1 (de) | Anti-ailim antikörper zur behandlung von crohn's | |
ATE297922T1 (de) | Isoindolin-1-on als glukokinaseaktivatoren | |
IS8058A (is) | Sýklísk súlfónamíð til að hamla gamma seytiasa | |
ATE233274T1 (de) | Oxyiminopregnancarbolactone | |
EA200300716A1 (ru) | Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6 | |
PL354030A1 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
MXPA04000891A (es) | Nuevos derivados de acido vinilcarboxilico y su uso como antidiabeticos. | |
YU40002A (sh) | Antipikornavirusna jedinjenja i kompozicije, njihove farmaceutske upotrebe, i materijali za njihove sinteze | |
DE602004023762D1 (de) | Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren | |
MY139368A (en) | Novel cyclohexyl sulphones | |
DE3767287D1 (de) | Potenzierung von prazosin. | |
MXPA06001974A (es) | Nuevos oxidos de sulfenamida. |